High Court Refuses To Hear 'Skinny Label' Drug Patent Case
The U.S. Supreme Court on Monday refused to review a Federal Circuit decision that put a spotlight on so-called skinny labels for generic drugs and resulted in Teva Pharmaceuticals being found...To view the full article, register now.
Already a subscriber? Click here to view full article